En Chu Kong Hospital
12
2
2
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Herbal Ointment in Treating Atopic Dermatitis Topically
Role: lead
Mobile-assisted Case Management for Panic Disorder
Role: lead
The Changes of Urine Growth Factors Level
Role: lead
Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture
Role: lead
Evaluation of Colchicine and Nonsteroidal Anti-inflammatory Drug Combination Therapy and Renal Function in Gout Patients
Role: lead
Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment
Role: collaborator
Laser Acupuncture and Acupressure for Low Back Pain
Role: lead
Post-Marketing Follow-Up of Long-term Type Ureteral Stent Set
Role: lead
Herbal Patch for Overactive Bladder
Role: lead
PG2 Injection 500 mg in Acute Stroke Study (Pass)
Role: collaborator
The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)
Role: collaborator
Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet
Role: collaborator
All 12 trials loaded